Citigroup Issues Pessimistic Forecast for Healthpeak Properties (NYSE:DOC) Stock Price

Healthpeak Properties (NYSE:DOC) had its target price lowered by investment analysts at Citigroup from $18.00 to $17.50 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage presently has a “neutral” rating on the real estate investment trust’s stock. Citigroup’s target price suggests a potential upside of 5.90% from the stock’s previous close.

DOC has been the subject of a number of other reports. Jefferies Financial Group cut Healthpeak Properties from a “buy” rating to a “hold” rating and dropped their price objective for the company from $21.00 to $17.00 in a research note on Monday, December 15th. The Goldman Sachs Group initiated coverage on Healthpeak Properties in a report on Friday, January 9th. They set a “neutral” rating and a $17.00 target price for the company. Weiss Ratings raised Healthpeak Properties from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, January 26th. Cantor Fitzgerald set a $17.00 price target on shares of Healthpeak Properties in a research note on Monday, January 5th. Finally, Evercore reduced their price target on shares of Healthpeak Properties from $21.00 to $19.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 4th. Six research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Healthpeak Properties presently has an average rating of “Hold” and a consensus target price of $19.27.

Healthpeak Properties Stock Performance

Shares of DOC stock opened at $16.53 on Wednesday. The company has a debt-to-equity ratio of 1.21, a quick ratio of 2.82 and a current ratio of 2.82. The firm has a market cap of $11.49 billion, a P/E ratio of 165.27, a P/E/G ratio of 8.77 and a beta of 1.10. The firm’s 50 day moving average price is $17.10 and its 200-day moving average price is $17.46. Healthpeak Properties has a one year low of $15.71 and a one year high of $20.10.

Healthpeak Properties (NYSE:DOC) last posted its earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share for the quarter, beating the consensus estimate of $0.45 by $0.02. Healthpeak Properties had a net margin of 2.52% and a return on equity of 0.84%. The firm had revenue of $719.40 million during the quarter, compared to the consensus estimate of $685.14 million. During the same quarter last year, the firm earned $0.46 EPS. The firm’s revenue for the quarter was up 3.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. As a group, equities research analysts predict that Healthpeak Properties will post 1.86 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Mather Group LLC. purchased a new stake in Healthpeak Properties during the 3rd quarter worth about $25,000. City Holding Co. acquired a new stake in Healthpeak Properties in the 3rd quarter valued at about $26,000. WPG Advisers LLC boosted its stake in shares of Healthpeak Properties by 270.2% in the 4th quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust’s stock valued at $26,000 after buying an additional 1,197 shares during the period. Advocate Investing Services LLC acquired a new position in shares of Healthpeak Properties during the fourth quarter worth about $26,000. Finally, Rexford Capital Inc. acquired a new position in shares of Healthpeak Properties during the second quarter worth about $28,000. 93.57% of the stock is currently owned by hedge funds and other institutional investors.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.